ISSN 1806-0013 printed version
ISSN 2317-6393 on-line version



Scope and Policy

The Revista Dor Pesquisa Clínica e Terapêutica (Rev Dor) (ISSN- 1806-0013) is the medical journal of the Sociedade Brasileira para o Estudo da Dor (SBED) (the Brazilian Society for the Study of Pain), a quarterly publication aiming at promoting scientific articles that bring contributions for a better knowledge in the study of pain and updates for health professionals.

Editorials are developed by the editor or on his behalf and are published in the current edition of the journal (maximum limits: 1,000 words, title, 2 figures or tables in total and 10 references).

Original Articles

Original articles present complete trials with novel results (maximum limits: 3,000 words, title, structured abstract, 7 pictures or tables in total and 40 references). The evaluation of submitted papers will follow the priorities of new and relevant information confirmed by a study with appropriate methodology.

Papers introducing speculative conclusions that are not results confirmed or based on a study, and that bear inadequate methodology will not be accepted.

Case Reports

Case reports or case series shall be considered for publication if they describe uncommon and original findings or when the report introduces clinical or surgical responses that help in pathophysiological solutions of some disease (maximum limits: 3,000 words, title, abstract, 4 pictures or tables in total, and 10 references).

Review Papers

Review papers come as spontaneous demand or by invitation (maximum limits: 4,000 words, title, abstract, 8 pictures or tables in total and 70 references).


Editorial Process

All requirements found in the instructions to the authors must be met, so that the papers can be included in the editorial process. The editorial secretariat will inform about non-conformities on the submission of the paper. After notice the author will have a deadline of 20 days to make the necessary adjustments to his/her paper. All papers will be submitted to the judgment of two (02) to four (04) reviewers that have up to 20 days to make their evaluation. Authors have to provide guarantees that no material violates any existing copyright or third party's rights.

When received, papers are subject to corrections or standard editorial changes without any changes to the content of the study. If not accepted, papers shall be returned in their original format with a justification by the editor.
Approved papers will be forwarded to the author in a PDF file for typographic corrections and shall be returned within five (05) days. Any delay in returning the file entitles the Editor to publish it without the final correction.


Articles shall be sent via email to:, except for the document of Copyrights Assignment available in the portal:, that has to be properly signed by the author(s) and forwarded by regular mail to the Society address (Av. Conselheiro Rodrigues Alves, 937 – Cj. 2 - Vila Mariana - 04014-012, São Paulo, SP - Brasil). The email text shall include the rights of exclusivity for publication in Rev Dor if the article is approved. The articles can be submitted in Portuguese, English, and Spanish but the printed publication will be in Portuguese only, whereas the electronic publication will take place in Portuguese and in English. The authors are accountable for and should state any conflict of financial interests or of any other kind and shall also acknowledge any financial support received for the study.
Approval for Publication

After the articles are accepted, they become subject to minor corrections or editing standardization changes that do not change the author's style. Any changes in the format, style, or interpretation should only take place after previous consultation.

Final Correction

The articles to be published shall be forwarded to the author in PDF file for the appropriate corrections and shall be returned within one week. Any delay in the process of returning the corrected files entitles the Editor to publish them regardless the final correction. The articles will be forwarded to their authors via the electronic address informed as correspondence address, and the author is the sole responsible for the final appreciation of the content; other authors will be considered as agreeing with its publication.


Title: The title of the article shall be short, clear and concise to facilitate its classification. A sub-title may be used if necessary. It shall be submitted in Portuguese and in English.
Author(s): The full name of the author(s) and their affiliations to Institutions, address, phone number, fax, and electronic address. The name of the institution where the study was carried out shall be informed. Acknowledgements to other collaborators may be mentioned at the end, before the references.

Abstract: Shall be structured with maximum of 250 words.

For Research and Clinical Trials highlight: Background and Objectives, Methods, Results and Conclusion.

For case studies, highlight: Background and Objectives, Case Report and Conclusion.

For review articles highlight: Background and Objectives, Contents and Conclusion.

For all papers five (05) keywords shall be indicated. The use of DeCS – Keywords in Health Sciences – is recommended and is available at:

Abstract: Abstract shall be translated into English by specialized translator from Rev Dor's.


The submission of research articles describing experimental research in humans or animals implies that the authors received the appropriate approval from the Ethics Committee that they are in compliance with the Declaration of Helsinki. A statement of such effect shall be included in the chapter “Methods”. Generic names of substances shall be deployed. Whenever trade names are used in the research, such names shall be included in brackets in the chapter “Methods”.

It shall be structured as follow:

Introduction – this session shall be written according to the opinion of the researchers without knowledge of specialist in the area and shall clearly present – and if possible illustrate – the foundation for the research and its objectives. Clinical research report shall, whenever appropriate, include an abstract on literature research to show the reasons why the study was necessary, and that the study aims at contributing to field applications. This session shall be closed with a short statement of what is being described in the article.

Methods – it should include the design of the study, scenario, type of participants or materials deployed a clear description of interventions and comparisons, and the type of analysis used including the power of calculations, if appropriate.

The number of the process and the year of the Ethics Committee of the Institution shall be included in original articles.

Results – Results of statistical analysis should include, whenever appropriate, the relative and absolute risks or risks reductions, and confidence intervals.

Discussion – This session may be subdivided into subtitles with short and informative readings.

Conclusion – A clear description of primary conclusions of the research and a clear explanation of their importance and relevance.

References – There shall be no more than 15 references.

Figures and tables: should be submitted separated from the article main text.


Reports of clinical cases related to pain study and therapy shall be submitted as follows: Introduction, Case Report, Discussion and References.


This is a synthesis article, on well-established topics with a critical analysis of queried references and conclusions, systematic reviews related to pain study and therapy. It shall not exceed 2,000 words. It should bear the following structure: Introduction, Contents, Conclusion, and References. It shall not exceed 40 references.


We welcome comments about any article published in the journal. Usually, they are not reviewed, but occasionally responses to letters are welcome and published on the same edition of the journal. Letters not exceeding 400 words and five references or less are preferred (the first to be referred to should be the Rev Dor article itself). The authors should also include personal data and full address (including phone number and email address). All letters are edited and forwarded to the authors before publication.

References: No more than 30.


We would like to remind you that, although many of our readers are experts, their expertise may not lie in your specific area, so it is necessary to explain all the terminology and acronyms the very first time they are deployed in the text; they shall be written in full with the acronym in brackets. After that, the acronym may be used alone.


Rev Dor adopts the Vancouver standards for article references and the presentation shall follow the format proposed by the International Committee of Medical Journal Editors (ICMJE), ac- cording to the examples below:

Journal titles shall be abbreviated according to the style found in the List of Journal Indexed in Index Medicus, of the National Library of Medicine. Site available at: List of Journal Indexed in Index Medicus

To the references, list the first six (06) authors and then et al. ICMJE proposed format Examples of References

Articles in Journals:

Duggirala S, Lee BK. Optimizing cardiac resynchronization therapy for congestive heart failure. Curr Probl Cardiol. 2013;38(6):215-37.

Over six (06) authors:

Pinto RZ, Maher CG, Ferreira ML, Hancock M, Oliveira VC, McLachlan AJ, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):865-77.

Articles with attachments:

Adedapo KS, Fadiji IO, Orunmuyi AT, Onimode Y, Osifo BO. Radioactive iodineablation therapy: a viable option in the management of Graves’ disease in Nigeria. Afr J Med Med Sci. 2012;41(Suppl:1):93-6.

Articles with “erratum

Gujral H, Tea C, Sheridan M. Evaluation of nurse’s attitudes toward adult patients of size. Surg Obes Relat Dis. 2011;7(4):536-40. Erratum in: Surg Obes Relat Dis. 2012;8(1):129-30.


Doyle AC, (editor.) Biological mysteries solved. 2nd ed. London: Science Press; 1991. p. 477.80.

Book chapter:

Lachmann B, van Daal GJ. Adult respiratory distress syndrome: animal models. In: Robertson B, van Golde LMG, (editors). Pulmonary surfactant. Amsterdam, 2nd ed. Batenburg: Elsevier; 1992. p. 635-63.


Their referral in the text is mandatory. Number the figures and tables in Arabic numbers including title and legend. Show in the text the preferred place to enter each figure (Include Figure X, for instance) Use B&W pictures. Pictures should only be used if vital for a good understanding of the text, and their number should not exceed three. The same result shall not be demonstrated by more than one illustration. Graphic signs used on tables or figures shall have their correlation as a footnote. Figures and tables should be forwarded separated from the article main text.

Deployment of Digital Resources:

Text in DOC format, figures with bars or lines should be for- warded in Excel spreadsheet (extension .XLS) (Figure 1, for example). Pictures or other kind of figures shall be digitized with minimum resolution of 300 DPI, in JPEG format. Do not include illustrations in the body of the text; each illustration should be forwarded in an individual file. The file name should indicate the type and number of the illustration (Picture 1, Table 2, for example). Titles and legends of the illustrations should be numbered and included in the text file. Copies or reproductions of other publications are allowed only with the express authorization of the Editor or of the Author of the originating article.


While describing trial with human beings, it should be mentioned that the procedures were carried out according to the ethical standards established by the Committee responsible for human trials (institutional or regional) and to the Declaration of Helsinki of 1975, reviewed in 1983.

Records of Clinical Trials:

The Rev Dor abides by the policies of the World Health Organization and of the ICMJE- (International Committee of Medical Journal Editors) for the registry of clinical trials, and recognizes the importance of such initiatives for the international disclosure of information about clinical research with open access. Thus and as of 2012, articles or studies previously recorded in a Clinical Trial Registry Platform that meets the requirements of the World Health Organization and of the International Committee of Medical Journal Editors will have the preference for publication. The list of the Clinical Studies Registry Platform can be found at, of the International Clinical Trials Registry Platform (ICTRP). Among them we find the Registro Brasileiro de Ensaios Clínicos (ReBEC) (Brazilian Registry of Clinical Trials), which is a free access, virtual platform for the registration of experimental and non-experimental studies in progress or completed by Brazilian and foreign researchers, and that can be accessed at Study registry number shall be published at the end of the abstract.

Deployment of Acronyms:

The use of acronyms should be minimal. Whenever long expressions have to be repeated, it is recommended that they be replaced by their initials in capital letters after they have already been mentioned once in the text. They shall be followed by their acronym in brackets. Every acronym included on tables and figures shall be explained on a footnote.

The quality of the pictures is sole responsibility of the authors.


[Home] [About the journal] [Editorial board] [Subscriptions]

Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License

Av. Conselheiro Rodrigues Alves, 937
Conj. 2 - Vila Mariana, 04014-012 - São Paulo - SP, Brasil
Tel.: 11 - 5904-3959
Fax: 11 - 5904-2881